(2020) MPA given orally during the first trimester for threatened miscarriage carried no specific risk for foetal abnormalities albeit the rate is higher than non-threatened pregnancies

Download our treatment cycle handbook

DOWNLOAD OUR DONOR INFORMATION BOOKLETS

DOWNLOAD OUR DONOR INFORMATION BOOKLETS